Resumo

RIVAS MARTINEZ, Noelia et al. Diabetic foot treated with graft obtained by bioprinter, about a series of cases. An. Fac. Cienc. Méd. (Asunción) [online]. 2024, vol.57, n.1, pp.82-88. ISSN 1816-8949.  https://doi.org/10.18004/anales/2024.057.01.82.

The risk of amputations in patients with diabetes is 10 to 20 times more frequent compared to non-diabetics. The biotechnological team developed by ROKIT Healthcare, Inc., of South Korean origin: Dr. INVIVO, is a biotechnology team that offers an effective therapy for the treatment of diabetic foot, with a hyper-personalized organ regeneration platform that, through artificial intelligence, scan the injury in order to manufacture a patch that contains autologous stem cells, extracellular matrix and specific tissue materials, to later apply it to the wound, and with this, achieve complete healing and regeneration. The purpose of this report aims to demonstrate the effectiveness of treatment in diabetic foot ulcers and present the results of 3 clinical cases with extensive injuries after lower limb amputations, treated at the District Hospital of Ñemby, Paraguay, using this technology.

Palavras-chave : diabetic foot; amputation; graft; bioprinter..

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )